In short
Levetiracetam, also known by the brand name Keppra, is an antiepileptic medication that has been the subject of several clinical trials to assess its effectiveness and safety in treating epilepsy. These studies have examined various formulations of levetiracetam, including oral tablets, extended-release versions, and intravenous infusions, across different age groups and types of seizures. The trials aim to provide valuable insights into the drug's pharmacokinetics, bioequivalence, and long-term effects in managing epilepsy symptoms.
At a glance
- Drug Formulations
- Oral tablets, Extended-release (XR) tablets, Intravenous (IV) infusion
- Age Groups Studied
- Children (4-16 years), Adults (18-55 years)
- Primary Conditions
- Epilepsy, Partial onset seizures
- Treatment Approaches
- Monotherapy, Adjunctive therapy
- Key Outcomes Measured
- Seizure frequency reduction, Seizure-free days, Pharmacokinetics, Safety and tolerability
- Study Durations
- Short-term (days to weeks), Long-term (months to years)
- Dosage Ranges
- 1000-3000 mg/day for adults, Weight-based dosing for children
- Safety Assessments
- Adverse events, Global Evaluation Scale ratings
- Pharmacokinetic Parameters
- Cmax, AUC, Tmax, Half-life, Clearance, Volume of distribution
- Bioequivalence Studies
- Comparing oral vs. IV formulations, Different manufacturers' formulations
What is Levetiracetam?
Levetiracetam is an antiepileptic drug (AED) used to treat various types of seizures. It is also known by its brand name Keppra. Levetiracetam is available in different forms, including oral tablets, oral solution, and intravenous (IV) infusion. This medication has been studied extensively in both adults and children with epilepsy.
What Conditions Does Levetiracetam Treat?
Levetiracetam is primarily used to treat the following conditions:
- Partial onset seizures: These are seizures that start in one specific area of the brain.
- Generalized tonic-clonic seizures: These seizures affect the entire brain and cause loss of consciousness and muscle contractions.
- Epilepsy: A neurological disorder characterized by recurrent seizures.
In some cases, Levetiracetam has also been studied for use in treating seizures associated with cerebral malaria, a severe complication of malaria infection that affects the brain.
How Does Levetiracetam Work?
While the exact mechanism of action is not fully understood, Levetiracetam is believed to work by binding to a specific protein in the brain called SV2A. This interaction helps to reduce abnormal electrical activity in the brain that causes seizures.
How is Levetiracetam Administered?
Levetiracetam can be administered in several ways:
- Oral tablets: These are taken by mouth, usually twice daily.
- Oral solution: This liquid form is useful for patients who have difficulty swallowing tablets.
- Extended-release tablets (Keppra XR): These are taken once daily and provide a steady release of the medication over time.
- Intravenous (IV) infusion: This method is used in hospital settings when oral administration is not possible.
The dosage of Levetiracetam varies depending on the patient's age, weight, and specific condition. It's important to take the medication exactly as prescribed by your doctor.
Efficacy of Levetiracetam
Clinical trials have shown that Levetiracetam is effective in reducing seizure frequency in both adults and children with epilepsy. Some key findings include:
- A significant reduction in partial onset seizure frequency compared to placebo.
- Effectiveness as monotherapy (used alone) in newly diagnosed epilepsy patients.
- Long-term efficacy and safety in children with epilepsy.
One study found that about 50% of patients experienced a reduction in seizure frequency of at least 50% when taking Levetiracetam.
Safety and Side Effects
Levetiracetam is generally well-tolerated, but like all medications, it can cause side effects. Common side effects may include:
- Drowsiness or fatigue
- Dizziness
- Weakness
- Headache
- Nausea
- Irritability or behavioral changes (especially in children)
Serious side effects are rare but may include severe mood changes, thoughts of self-harm, or allergic reactions. It's important to report any unusual symptoms to your healthcare provider.
Use in Special Populations
Levetiracetam has been studied in various patient groups:
- Children: It has shown efficacy and safety in pediatric patients with epilepsy, including infants as young as 1 month old.
- Elderly: Dose adjustments may be necessary in older adults, especially those with reduced kidney function.
- Pregnant women: While data is limited, Levetiracetam is considered to have a relatively low risk during pregnancy compared to some other antiepileptic drugs. However, the potential risks and benefits should be discussed with a healthcare provider.
Ongoing Research
Research on Levetiracetam continues to explore its potential uses and optimize its administration. Some areas of ongoing study include:
- Use in treating seizures associated with cerebral malaria in children.
- Comparison of extended-release formulations (Keppra XR) with standard formulations.
- Long-term safety and efficacy studies in various patient populations.
These ongoing studies aim to further improve our understanding of Levetiracetam and its potential benefits for patients with epilepsy and other seizure disorders.